References
Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15, 4919–4927
Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66–70
Giebel LB, Strunk KM, Holmes SA, Spritz RA (1992) Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7, 2207–2217
Heideran MA, Pierce JH, Jensen RA, Matsui T, Aaronson SA (1990) Chimeric α and β-platelet derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the α-PDGF receptor and determine PDGF-AA binding specificity. J Biol Chem 265, 18741–18744
Kawagishi J, Kumabe T, Yoshimoto T, Yamamoto T (1995) Structure, organization, and transcription units of the human α-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30, 224–232
Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88, 9026–9030
Patterson C, Perrella MA, Hsieh C-M, Yoshizumi M, Lee M-E, Haber E (1995) Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem 270, 23111–23118
Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee M-E, Haber E (1996) Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98, 490–496
Patterson C, Wu Y, Lee M-E, DeVault JD, Runge MS, Haber E (1997) Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. J Biol Chem 272, 8410–8416
Pepper MS (1997) Manipulating angiogenesis. Circ Res 17, 605–619.
Rosnet O, Stephenson D, Mattei M-G, Marchetto S, Shibuya M, Chapman VM, Birnbaum D (1993) Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8, 173–179
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman M, Schuh A (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66
Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519–524
Spritz RA, Strunk KM, Lee S-T, Lu-kuo JM, Ward DC, le Paslier D, Altherr MR, Dorman TE, Moir DT (1994). A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics 22, 431–436
Sternberg NL (1992) Cloning high molecular weight DNA fragments by the bacteriophage P1 system. Trends Genet 8, 11–16
Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677–1683
Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203–212
Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181–1190
Author information
Authors and Affiliations
Additional information
The nucleotide sequence data reported in the paper have been submitted to GenBank and have been assigned the accession number AF035121.
Rights and permissions
About this article
Cite this article
Yin, LY., Wu, Y., Ballinger, C.A. et al. Genomic structure of the human KDR/flk-1 gene. Mammalian Genome 9, 408–410 (1998). https://doi.org/10.1007/s003359900783
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s003359900783